Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys in HBeAg Positive Chronic Hepatitis B
NCT01519921Phase 4Completed
- Sponsor
- Roche
- Start
- Oct 2005
- Primary completion
- Jun 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by Roche. Started Oct 2005; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01519921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519921.